about the author

Derek Graf

dgraf@endpointsnews.com
Derek Graf on LinkedIn

author articles

Swat­ting away a takeover at­tempt, Zymeworks keeps re­tool­ing staff; Af­ter Cyg­nal-ing her ex­it from Flag­ship, Pearl ...

3 years ago
Peer Review

As law­suit car­ries on against Guardant Health, CFO shake­up hits Il­lu­mi­na; Pfiz­er-backed biotech taps CEO to lead ...

3 years ago
Peer Review

Amarin fish­es for an­oth­er CFO as down­siz­ing takes hold; Cure­Vac makes a deal, then lines up No­var­tis ex­ec to lead ...

3 years ago
Peer Review

Time Pas­sages: Bruce Gold­smith out at Jim Wilson's gene ther­a­py biotech; Flag­ship re­veals Michael Sev­eri­no’s CEO ...

3 years ago
Peer Review

Hel­lo, I must be go­ing: Jorge Gomez is Mod­er­na CFO for on­ly a day; As set­backs mount, In­ovio’s Joseph Kim choos­es ...

3 years ago
Peer Review

Mov­ing on from Us­ama Ma­lik's in­sid­er trad­ing im­broglio, Fore re­sets at the top; Take­da spin­out turns to Neu­rana CEO ...

4 years ago
Peer Review

Let’s build some­thing to­geth­er: Ex-Lowe’s CFO to join Pfiz­er while Mod­er­na’s David Meline re­tires; The ...

4 years ago
Peer Review

Changes in high-rank­ing ex­ecs poised to deep­en at Karyopharm; Till­man Gern­gross-chaired biotech pro­motes new med­ical ...

4 years ago
Peer Review

Roger Perl­mut­ter lures Roy Baynes away from Mer­ck; Now, Voy­ager: Al San­drock be­comes a CEO af­ter break from Bio­gen

4 years ago
Peer Review

Zai Lab gives Josh Smi­ley a sec­ond chance in a prime role; De­nali gets ready to re­arrange staff as clin­i­cal hold ...

4 years ago
Peer Review

Centes­sa gives An­toine Yver a new role, brings his old col­league on board; Pre­lude to a change: Jane Huang sets up ...

4 years ago
Peer Review

Till­man Gern­gross leads a pack of biotech CEOs out the door; With eyes on pipeline ex­pan­sion, Po­sei­da woos a gene ...

4 years ago
Peer Review

Blue­print Med­i­cines gets more ducks in a row be­fore CEO tran­si­tion; Paul Stof­fels has his work cut out for him at ...

4 years ago
Peer Review

As Hal Bar­ron steals the show, there’s no off po­si­tion on the John Maraganore switch; Dan­ny Bar-Zo­har makes an­oth­er ...

4 years ago
Peer Review

Er­ic Os­tertag reach­ing the end of the line as Po­sei­da chief, will be­come ex­ec­u­tive chair­man; Alec­tor ex­ec named CEO ...

4 years ago
Peer Review

Joan Shen ends the year by say­ing good­bye to I-Mab; CRISPR Ther­a­peu­tics puts coal in R&D chief's stock­ing

4 years ago
Peer Review

Tak­ing a leave of ab­sence, Am­pio Phar­ma­ceu­ti­cals CEO pass­es ba­ton to a new board mem­ber; Ax­el Hoos' can­cer biotech ...

4 years ago
Peer Review

Al­ny­lam’s John Maraganore isn’t the on­ly CEO to leave his post; CRISPR’s chief com­mer­cial of­fi­cer takes the ...

4 years ago
Peer Review

Flag­ship turns to No­var­tis HR gu­ru in lat­est ad­di­tion; David Grainger sad­dles up to new po­si­tion at Centes­sa while ...

4 years ago
Peer Review

With Mav­er­ick now in Takeda's hands, James Sci­bet­ta turns the page; Roivant CMO leaves in fa­vor of small IL-2 biotech

4 years ago
Peer Review

A Pfiz­er part­ner wel­comes ex-ADC Ther­a­peu­tics CMO Jay Fein­gold to the team; Amid tough sled­ding, Im­muno­vant choos­es ...

4 years ago
Peer Review
A service from the Financial Times